Nigel Gordon is a experienced capital markets and M&A lawyer, helping entrepreneurial and high-growth companies navigate the complex listing process on LSE’s Main and AIM markets and the AQSE market, acting for issuers and for brokers and financial advisers. He prides himself on being able to cut through the complexity and summarise concepts with clear, straightforward explanations of the rules and the commercial impact on his clients. He has been actively involved in the AIM Market since inception in 1995, and has acted as company secretary to a number of listed and AIM companies. He also advises his clients on both public and private M&A transactions.
Nigel represents clients across industries ranging from mining to cleantech and healthcare, with an emphasis on the natural resources, healthcare, property and financial services sectors. His experience of going down two working gold mines in Africa has given him an understanding of the mining industry and its day-to-day challenges.
Nigel has a Law degree and qualified as a solicitor in 1987. He has been a partner in both the London office of an international firm and another central London firm. He joined Druces in May 2025. His interests include swimming, cycling, playing bridge and supporting Chelsea.
Chambers
Nigel has been recognised by Chambers as a “Leader in their field” within “Energy & Natural Resources: Mining: International” and he is ranked by Chambers in the Capital Markets: AIM category.
Clients have said “Nigel gets the right balance between the black letter law and the commercial practicality”.
Experience
- Advising Pan African Resources on the £107m acquisition of Evander Gold Mines from Harmony Gold Mining, and on the rights issue which raised approximately £50m, which partially funded the acquisition, and on a placing and vendor placing raising an aggregate of approximately £55m.
- Advising KCR Residential REIT on its admission to AIM, two acquisitions and several fundraisings.
- Advising Kiwara on its acquisition by First Quantum Minerals for approximately £260m by way of a scheme of arrangement.
- Advising TSX and NASDAQ listed TransGlobe Energy Corporation on its admission to AIM (with a market capitalisation on admission of approximately £135 million) by way of the AIM Designated Market route.
- Acting for Pan African Resources on the US$235 million court-approved cancellation of its share premium account
- Advising Synairgen on several secondary placings.
- Acting for Mydecine Innovations Group (a pre-revenue biopharmaceutical company listed on the CSE) on its dual listing on Aquis.
- Advising Xtract Resources on the AIM requirements for the disposal of its Manica Gold project in Mozambique for a consideration of up to US$15 million.
